Tymlos (Radius Health, Inc.)


Welcome to the PulseAid listing for the Tymlos drug offered from Radius Health, Inc.. This Parathyroid Hormone-Related Peptide Analog [EPC],Parathyroid Hormone-Related Protein [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Radius Health, Inc.
NON-PROPRIETARY NAME: abaloparatide
SUBSTANCE NAME: ABALOPARATIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Parathyroid Hormone-Related Peptide Analog [EPC],Parathyroid Hormone-Related Protein [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-05-01
END MARKETING DATE: 0000-00-00


Tymlos HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTymlos from Radius Health, Inc.
LABELER NAME: Radius Health, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2000(ug/mL)
START MARKETING DATE: 2017-05-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70539-001_15395e7c-def6-4993-be31-7a3e238808ed
PRODUCT NDC: 70539-001
APPLICATION NUMBER: NDA208743

Other ABALOPARATIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Radius Health, Inc.Tymlos